COVID-19-docs-english-version
2021/03/25 – 11h30
>>> COVID-19-Docs english version
Les articles de la Revue Respiratory Medicine and Research
© 2020 SPLF and Elsevier Masson SAS. All rights reserved.
• Venous thromboembolism and COVID-19 (pdf)
https://doi.org/10.1016/j.resmer.2020.100759 2590-0412
Keywords : Coronavirus disease – COVID-19 – SARS-CoV-2 – Pulmonary embolism – Venous thromboembolic disease
• Respiratory support in patients with COVID-19 (outside intensive care unit). A position paper of the Respiratory Support and Chronic Care Group of the French Society of Respiratory Diseases (pdf)
https://doi.org/10.1016/j.resmer.2020.100768
Keywords :
• Pulmonary embolism among critically ill patients withARDS due to COVID-19 (pdf)
https://doi.org/10.1016/j.resmer.2020.100789
Keywords :
• Proposals for managing patients with thoracic malignancies during COVID-19 pandemic (pdf)
https://doi.org/10.1016/j.resmer.2020.100769
Keywords :
• Prognostic value of lung ultrasound and its link with inflammatory biomarkers in patients with SARS-CoV-2 infection (pdf)
https://doi.org/10.1016/j.resmer.2020.100809
Keywords :
• Paediatric aspects of COVID-19: An update (pdf)
https://doi.org/10.1016/j.resmer.2020.100765
Keywords : COVID 19 – Paediatric: Clinical aspects
• Nebulization: A potential source of SARS-CoV-2 transmission (pdf)
https://doi.org/10.1016/j.resmer.2020.100778
Keywords : Polyenes – Mucorales – Antifungal drugs – Azoles – Prophylaxis – Nebulization
• Management of asthma during the Coronavirus disease 2019 outbreak (pdf)
https://doi.org/10.1016/j.resmer.2020.100762
Keywords : Asthma – Covid19
• Letter to the Editor in response to the article: “Nebuliza-tion: a potential source of SARS-CoV-2 transmission” (pdf)
https://doi.org/10.1016/j.resmer.2020.100802
Keywords :
• Impact of the Covid-19 pandemic and lung transplantation program in France (pdf)
https://doi.org/10.1016/j.resmer.2020.100758
Keywords : Lung Transplantation – COVID 19 – SARS-CoV-2 – Drug shortage – Telemedicine
• Impact of the COVID-19 lockdown on patients suffering from idiopathic interstitial pneumonia (pdf)
https://doi.org/10.1016/j.resmer.2020.100808
Keywords : COVID-19 – Lockdown – Idiopathic interstitial pneumonia – Idiopathic pulmonary fibrosis
• Immunosuppression in a lung transplant recipient withCOVID-19? Lessons from an early casea (pdf)
https://doi.org/10.1016/j.resmer.2020.100782
Keywords : SARS-CoV-2 – Lung transplantation – Immunosuppressants – Protease inhibitors –Therapeutic drug monitoring
• Delayed pulmonary abscess following COVID-19 pneumonia: A case report (pdf)
https://doi.org/10.1016/j.resmer.2020.100776
Keywords : COVID-19 – Pneumonia Pulmonary abscess
• COVID-19 spread: The Italian case (pdf)
https://doi.org/10.1016/j.resmer.2020.100771
Keywords : Covid-19 – Pneumonia
• Covid-19 pneumonia and pulmonary vascular disease: A UK Centre perspective (pdf)
https://doi.org/10.1016/j.resmer.2020.100781
Keywords : Coronavirus – Pulmonary hypertension – Royal Brompton Hospital London UK – Pulmonary embolism – Intensive care – ECMO – Guidelines
• COVID-19 in a patient with idiopathic pulmonary fibro-sis successfully treated with Ruxolitiniba (pdf)
https://doi.org/10.1016/j.resmer.2020.100799
Keywords : SARS-CoV-2 – Covid-19 – JAK inhibitors – Idiopathic pulmonary fibrosis
• COVID-19 and Pneumocystis jirovecii pneumonia: Backto the basicsa (pdf)
https://doi.org/10.1016/j.resmer.2021.100814
Keywords : COVID-19 – Pneumocystis – Jirovecii – Pneumocystosis
• Covid-19: Adapting the geriatric organisations to respond to the pandemic (pdf)
https://doi.org/10.1016/j.resmer.2020.100774
Keywords : Coronavirus disease – Covid-19SARS-CoV-2 – Elderly.
• Clinical characteristics of and outcomes for patients with COVID-19 and comorbid lung diseases primarily hospitalized in a conventional pulmonology unit: A retrospective study (pdf)
https://doi.org/10.1016/j.resmer.2020.100801
• Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges (pdf)
https://doi.org/10.1016/j.resmer.2020.100764
Keywords : COPD – COVID-19 – Infection
• Bronchoscopy use in the COVID-19 era (pdf)
https://doi.org/10.1016/j.resmer.2020.100760
• Alveolar lymphocytosis with plasmacytosis in severeCOVID-19 (pdf)
https://doi.org/10.1016/j.resmer.2020.100784
Keywords : COVID-19 – SARS-CoV-2 – Pneumonia – Bronchoalveolar lavage fluid – Critical care
• A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavira (pdf)
https://doi.org/10.1016/j.resmer.2020.100780
Keywords : COVID-19 – Human immunodeficiency virus – Lopinavir – Pneumonia – Pulmonary embolism
Documents en anglais émanants des groupes de travail de la SPLF
• Procedure for the pulmonary management of non-ICU patients hospitalized in the context of the COVID-19 pandemic
C. Rabec, J.Gonzalez-Bermejo for the working group (GAVO2) of SPLF
• Proposals for the management of COPD patients in the context of the COVID-19 epidemic G (pdf)
Deslée, M Zysman, L Boyer, N Roche, PR Burgel for the COPD group Version dated 29/03/2020
• Proposals for managing patients in the context of the COVID-19 pandemic (pdf)
Writing: group of experts including the French Oncology group, the SPLF and the IFCT as
• Position of the Asthma and Allergy Working Group (G2A) of the SPLF on the management of asthma patients during the COVID-19 epidemic (pdf)
• Information note on the use of nebulizers during the Covid-19 epidemic (pdf)
JC Dubus, G Reychler, L Vecellio; on March 15, 2020 for the working group on aerosol therapy (GAT) of SPLF
